Related references
Note: Only part of the references are listed.Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance
Margaritis Avgeris et al.
BIOLOGICAL CHEMISTRY (2012)
A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival
Jyotsna Batra et al.
BMC CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data
Jyotsna Batra et al.
PLOS ONE (2011)
Kallikrein-Related Peptidase 4 Gene (KLK4) in Prostate Tumors: Quantitative Expression Analysis and Evaluation of Its Clinical Significance
Margaritis Avgeris et al.
PROSTATE (2011)
Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway
Lin Gao et al.
BIOLOGICAL CHEMISTRY (2010)
Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides
Can Hekim et al.
BIOLOGICAL CHEMISTRY (2010)
KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone
Konstantinos Mavridis et al.
BIOLOGICAL CHEMISTRY (2010)
Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies
Margaritis Avgeris et al.
BIOLOGICAL CHEMISTRY (2010)
Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia
Konstantinos Mavridis et al.
CANCER SCIENCE (2010)
Prostate Cancer Screening with Prostate-Specific Antigen Testing: More Answers or More Confusion?
Eleftherios P. Diamandis et al.
CLINICAL CHEMISTRY (2010)
Prognostic value and biological role of the kallikrein-related peptidases in human malignancies
Konstantinos Mavridis et al.
FUTURE ONCOLOGY (2010)
Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1
Wenbin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy
Anja Rabien et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication
Andrew Vickers et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
E. A. M. Heijnsdijk et al.
BRITISH JOURNAL OF CANCER (2009)
Utilizing the Molecular Gateway: The Path to Personalized Cancer Management
Jonathan B. Overdevest et al.
CLINICAL CHEMISTRY (2009)
Quantitative Analysis of Human Kallikrein 5 (KLK5) Expression in Prostate Needle Biopsies: An Independent Cancer Biomarker
Dimitrios Korbakis et al.
CLINICAL CHEMISTRY (2009)
Prostate kallikrein markers in diagnosis, risk stratification and prognosis
David Ulmert et al.
NATURE REVIEWS UROLOGY (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival
Joseph R. Sterbis et al.
CLINICAL CANCER RESEARCH (2008)
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: A critical analysis of the literature
Shahrokh F. Shariat et al.
CLINICAL CANCER RESEARCH (2008)
Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
Girish Sardana et al.
CLINICAL CHEMISTRY (2008)
Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs)
Andrew J. Ramsay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prostate-specific kallikreins-2 and-4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and-2
Gregory J. Mize et al.
MOLECULAR CANCER RESEARCH (2008)
High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse
Anja Rabien et al.
TUMOR BIOLOGY (2008)
Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer
Jin Gao et al.
PROSTATE (2007)
PSA and other tissue kallikreins for prostate cancer detection
Carsten Stephan et al.
EUROPEAN JOURNAL OF CANCER (2007)
Prostate-specific antigen induces apoptosis of osteoclast precursors: Potential role in osteoblastic bone metastases of prostate cancer
Masato Goya et al.
PROSTATE (2006)
Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level
RS Punglia et al.
CANCER (2006)
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells
TL Veveris-Lowe et al.
ENDOCRINE-RELATED CANCER (2005)
Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer
P Stavropoulou et al.
CLINICA CHIMICA ACTA (2005)
Management of prostate-specific antigen relapse in prostate cancer: A European consensus
L Boccon-Gibod et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2004)
The emerging roles of human tissue kallikreins in cancer
CA Borgoño et al.
NATURE REVIEWS CANCER (2004)
Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues
GM Yousef et al.
PROSTATE (2003)
Prognostic value of the human kallikrein gene 15 expression in ovarian cancer
GM Yousef et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Serum human glandular kallikrein (hK2) and insulin-like growth factor I (IGF-I) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination WithTotal and %free PSA
A Scorilas et al.
PROSTATE (2003)
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
M Han et al.
JOURNAL OF UROLOGY (2003)
Quantitative analysis of kallikrein 15 gene expression in prostate tissue
C Stephan et al.
JOURNAL OF UROLOGY (2003)
The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
GM Yousef et al.
BRITISH JOURNAL OF CANCER (2002)
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
GM Yousef et al.
PROSTATE (2002)
Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3
H Koistinen et al.
PROSTATE (2002)
Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3
S Réhault et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR
TK Takayama et al.
BIOCHEMISTRY (2001)
Molecular cloning of the human kallikrein 15 gene (KLK15) -: Up-regulation in prostate cancer
GM Yousef et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
